AOD9604 is a modified fragment of human growth hormone (HGH) engineered to support fat metabolism without stimulating growth pathways. In research settings it’s used to study lipolysis (fat breakdown) and the inhibition of lipogenesis (new fat formation). Originally developed as potential obesity treatment as it appears to promote fat breakdown without the growth promoting or blood sugar effects of full HGH. Ideal for reduction of body fat, improving body composition and targeting stubborn fat areas.
